chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One week after administration, I had sudden onset inability to move left arm. I was transported to ER immediately. Treated, scanned with CT of brain, MRI of brain, c-spine and brachioplexus. In hospital for 2 days and no answers. Still no answers to left arm paresthesia and proprioreceptor deficits. Spreading into left leg and mild systemic symptoms. I have been to the ER, seen by primary physician, Physiatrist and Neurology and Occupational Therapy. I am scheduled for many more appointments and trying to find and answer.
Within an hour of vaccine, I had significant shortness of breath and If I have a reaction I lose my voice and I became horse. I started my burst of prednisone and I did that for 4 days and tapered and albuterol nebulizer every 3-4 hours and also began the rest of my inhalers the next day. I set me back a good 2 weeks. My doctor advised me not to get the 2nd dose of Moderna and I got the J&J and I had a worse reaction to that.
Information has been received from a registered nurse concerning an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical histories and concomitant therapies were not reported. On unspecified dates, the patients were vaccinated with doses of improperly stored PROQUAD (lot # M011660 with expiration date 08-SEP-2017; dose and route were unknown). The vaccines were exposed to temperature excursion of 40 degrees Fahrenheit for 5 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
swelling on her right eye; she is experiencing soreness and numbness on her left arm (vaccination site); she is experiencing  soreness and numbness on her left arm (vaccination site); This is a spontaneous report from a contactable consumer (patient). A 26-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot/batch number was not reported) via an unspecified route, administered in left arm on 21Apr2021 as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On the day of reporting (22Apr2021), she was experiencing swelling on her right eye and soreness and numbness on her left arm (vaccination site) and would like to know/confirm if this was a commonly reported side effect post-administration of the vaccine as she had read on the fact sheet that swelling of the face was included on the expected/commonly reported side effects. Also, she would like to know if this went away and if she could put anything or take any medications. The outcome of events was unknown.  No follow-up attempts were needed, information about lot/batch number could not be obtained.
Fever of 104F. Lethargic. Tired. Hands and feet hurt.  Lasted 2 days.  Day 2 child complained of achy throat.
Patient is a 75-year-old woman with history of COPD (on 3 L NC at home) and diastolic heart failure presented to the local ED with worsening shortness of breath.   Patient reports that she was in her usual state of health until around two days prior to admission.  She reports that she has chronic shortness of breath, but that this acutely worsened starting around 2 days prior to admission.  She reported feeling short of breath with any exertion.  She denied having any chest pain. She reports having a chronic cough.  She reported having some sinus congestion, which seems to be a chronic issue.  She reports that she has had some chills over the last 2 days, but denies any fevers.  Due to persistence of the symptoms patient presented to a local clinic where she was noted to be having an increased oxygen requirements up to 5 L.  She then tested positive for COVID-19.  She was then instructed to present to the local ED for further evaluation.    Upon arrival to the local ED, patient was noted to be hypoxic and was needing up to 10 L nasal cannula to maintain oxygen saturations.  She was borderline hypotensive at times, but blood pressures remained stable with SBP in the 100's.  Admission lab work was notable for creatinine elevated to 1.7.  BNP elevated to 2000.  ABG showed hypoxia on 5 L nasal cannula.  Rapid COVID test was positive.  CXR showed cardiomegaly with bilateral infiltrates (possibly chronic interstitial findings).  Patient was given IV Decadron in the ED.  Hospital was then contacted for admission.    Of note, patient was fully vaccinated against COVID-19.  She reports that she completed a 2 dose mRNA vaccine series in 2/2021.  She reports that she has been boosted, but was unable to remember the date when she was boosted.    PT REMAINS INPATIENT AT THIS TIME.
Client presented to the vaccination site on 11/6/2021. The client notified PHN that she received 2 doses of AstraZeneca COVID vaccine, 2nd dose on 4/30/2021. PHN submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID vaccine Pfizer as booster. Per CDC guidance, approval to proceed with COVID vaccine Pfizer booster was obtained from medical consult team via text message from PHN Supervisor, Vaccine Operations Lead. Client received COVID vaccine Pfizer (lot# FF8839) on 11/6/2021 at 1515. The client did not report any symptoms during the 30 minute observation period. Vaccinator Pharmacist educated client on possible adverse reactions and when to seek medical care. The client left the vaccination site at 1545 walking with steady gait.
Fever and sore neck for 2 days, then a mild rash break out all over her body.
Within 24 hrs status post FLUVIRIN vaccine, employee developed severe nausea/vomiting, stomach cramping and fatigue causing her to call in "sick" to work.
shooting pain from shoulder down to hand; rash is inflamed; shooting pain from shoulder down to hand; developed a rash on her left arm extending from arm to elbow and upto shoulder; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (shooting pain from shoulder down to hand), INFLAMMATION (rash is inflamed), RASH (developed a rash on her left arm extending from arm to elbow and upto shoulder) and ARTHRALGIA (shooting pain from shoulder down to hand) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Aug-2021, the patient experienced RASH (developed a rash on her left arm extending from arm to elbow and upto shoulder). On an unknown date, the patient experienced PAIN IN EXTREMITY (shooting pain from shoulder down to hand), INFLAMMATION (rash is inflamed) and ARTHRALGIA (shooting pain from shoulder down to hand). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM DS) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (shooting pain from shoulder down to hand), INFLAMMATION (rash is inflamed) and ARTHRALGIA (shooting pain from shoulder down to hand) outcome was unknown and RASH (developed a rash on her left arm extending from arm to elbow and upto shoulder) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient used Ice for treatment medication. No Concomitant medication has been provided by reporter.
Breakthrough case admission/patient expired after 2 vaccines  Pfizer 1/15/21 lot# EL3249;  Pfizer 2/5/21 lot# EM9810
High fever (102.1 degrees orally, possibly higher since having difficulty with nasal breathing), congestion, very sore throat, multiple episodes of vomiting, rigors, lethargy, complaints of fatigue, muscle aches.
Information has been received from a certified medical assistant (CMA) concerning a 65 yr old white female with an unk medical history and unk allergies who on 19Sep05 at 17:00 was vaccinated IM, left deltoid with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). On the night of 19Sep05 (previously reported as within 48 hrs of being vaccinated), the pt developed redness and swelling at the injection. The pt had a mild pain and she took ibuprofen (Advil). She also felt low grade fever. The CMA reported that the pt developed cellulitis near injection site and tenderness from shoulder to elbow. The pt was treated with dicloxacillin. On 23Sep05, the pt recovered. There was no product quality complaint involved. The CMA also reported another pt who was vaccinated with the same lot number (WAES0509USA03585). Additional information is not expected.
This spontaneous report as received from a consumer refers to her daughter, a 22 year old female patient with no pertinent medical history or drug reactions/allergies. The patient was vaccinated with her first, second dose of M-M-R II (manufacturer unspecified) (dose, frequency, lot#, expiration date not reported) approximately in May 1992 ("at 18 months of age") and 1995 (about 4.5 and 5 years old respectively). There was no concomitant medication On 12-AUG-2013, the patient vaccinated with a booster dose of M-M-R II (dose, frequency, lot#, expiration date not reported). On 07-AUG-2013 ("an unspecified date 3 weeks ago") the patient showed low titer readings for the measles and mumps component during a routine test for immunity conducted for entry nursing school. Her titer for the rubella component was "good". As treatment for the low titer readings on the routine test conducted about three weeks ago, the patient received a booster dose of M-M-R II on 12-AUG-2013. She had not yet been retested on titer levels to determine her immune response. The outcome of the event was unknown. Additional information has been requested.
Fever, nausea, chills, fatigue until 52 hours after shot. Treated with 200mg ibuprofen and acetaminophen 500 mg alternating every 4-6 hours during those 52 hours.  72 hours after shot, a migraine developed. Treated with 100mg Imitrex. For five more nights, a migraine came on every night around 2:30am, in decreasing severity, for a total of 6 night-time onset migraines. First 4 treated with 100mg Imitrex, and last 2 treated with 50mg Imitrex.  I normally get 2-3 migraines per month, and never 6. I have never had more than 2 in a row.
Legs shaking; Adverse effect; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Legs shaking) and VACCINATION COMPLICATION (Adverse effect) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 003A21A) for COVID-19 vaccination.     The patient's past medical history included Unstable angina on 07-Mar-2021 and Kidney transplant in 2017. Concurrent medical conditions included Type 2 diabetes mellitus since 2007, Glaucoma since 2011, Hypertension since 2011 and Hyperthyroidism since 2018. Concomitant products included LABETALOL HYDROCHLORIDE (LABETOL) for Hypertension, TACROLIMUS from 2001 to an unknown date and PREDNISONE from 2001 to an unknown date for Kidney transplant rejection, METHIMAZOLE for Thyroid disorder, SIMVASTATIN for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (Legs shaking) and VACCINATION COMPLICATION (Adverse effect). At the time of the report, TREMOR (Legs shaking) and VACCINATION COMPLICATION (Adverse effect) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Blood glucose decreased: 146 (Low) Decreased. On 13-Mar-2021, Blood glucose increased: 246 (High) Increased.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment medications were unknown.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow-up information received on 07-MAY-2021 contains significant information: Added Patient's demographics, medical history and concomitant drugs.
Story told by Mom 12-3-07. In HD 10-18-07 *30 for well check and shots - Mom states had seizure in car at 530 PM. Mom driving. Mom present - stiff, drooling, unresponsive x 15 min per Mom - ambulance called and he woke up with them present - taken to ER - Mom states no fever at ER/no tx. To see doctor 10-19-07/ child had 2 previous seizures, both on same day 7-17-07 per Mom - had 103 fever per Mom/no tx by doctor 10-19-07 per mom.
Feverish; Clammy; Sweating; Nauseous; Felt a bit like a mild flu case; Mild headache; Received my booster on 16Sep2021; Received my booster on 16Sep2021; This is a spontaneous report from a contactable consumer (patient) reported for himself that: A 74-years-old male patient received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: FC3182) via an unspecified route of administration, administered in Arm Left on 16Sep2021 16:00 (Age at Vaccination 74-years-old) as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunization. Medical history included none. Concomitant medication(s) included valproate semisodium (DEPAKOTE) taken for an unspecified indication, start and stop date were not reported; quetiapine fumarate (SEROQUEL) taken for an unspecified indication, start and stop date were not reported; colecalciferol (VITAMIN D [COLECALCIFEROL]) taken for an unspecified indication, start and stop date were not reported. Past drug included Known allergies: A drug called Avelox. Patient receive did not any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient did not diagnose with COVID-19. Since the vaccination, patient did not test for COVID-19. Previously patient received first dose of dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: Gn5318) via an unspecified route of administration, administered in Arm Left on 07-FEB-2021 02:00 PM (Age at Vaccination 74-years-old) as DOSE 1 SINGLE for covid-19 immunization. Patient received second dose of dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Unknown. Obscured by other product labelling) via an unspecified route of administration, administered in Arm Left on 17-JAN-2021 04:00 PM (Age at Vaccination 74-years-old) as DOSE 2 SINGLE for covid-19 immunization. On 16Sep2021 16:00 the patient experienced felt a bit like a mild flu case and mild headache. On 27Sep2021 the patient experienced feverish, clammy, sweating, nauseous. received my booster off label use), received my booster on 16sep2021 (immunisation) on 16Sep2021. It was reported that I received my booster on 16Sep2021, at a nearby withheld. Felt a bit like a mild flu case for about a day and a half. It is now 02Oct2021 and everyday since the booster I have had a nagging but rather mild headache. On 27Sep2021 I was on a day trip, and I suddenly became very feverish, clammy, sweating, pretty bad headache, and felt nauseous. All of that took place over about a two hour period then it went away. However, as I stated earlier this somewhat mild but nagging headache has happened all day every day since I got my booster shot. Patient was did not received treatment. Device Date: 02Oct2021.The outcome of the events Felt a bit like a mild flu case, Feverish, Clammy, Sweating, Nauseous, was recovered in 2021. Mild headache was not recovered. received my booster on 16Sep2021 was unknown.    Follow-Up (11Oct2021): Follow-up attempts are completed. No further information is expected.
Left arm with 3" redness about 1" induration, on 2/23/03 at 5 p.m.
ON 01/19/2021, I HAD A SHARP PAIN IN MY LEFT CALF WHICH FELT LIKE A MUSCLE SPASM.  FOLLOWING THIS I BEGAN HAVING EDEMA IN THE LEFT FOOT, ANKLE, AND LOWER LEG ASSOCIATED WITH PAIN.  PAIN AND SWELLING WORSENED WITH PROLONGED STANDING DESPITE USE OF COMPRESSION SOCKS. VENOUS DOPPLER OF THE LEFT LOWER EXTREMITY OBTAINED AT MEDICAL CENTER ON 01/25/2021 SHOWED DVT. DR. ORDERED THE VENOUS DOPPLER AND THEN PRESCRIBED XARELTO FOR INITIAL TREATMENT.  I FOLLOWED UP WITH MY PCP WHERE ADDITIONAL PRESCRIPTION FOR MAINTAINANCE XARELTO ANTICOAGULATION FOR A TOTAL OF 6 MONTHS WAS GIVEN.
second shot was received- rash became worse; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 63-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 16Mar2021 13:30 (at the age of 63-year-old) as dose 2, single for covid-19 immunisation. Medical history included allergies: Senna laxatives, breast cancer from an unknown date and unknown if ongoing, psoriasis from an unknown date and unknown if ongoing, Rosacea from an unknown date and unknown if ongoing. Concomitant medications included anastrozole (ANASTRAZOLE DENK) taken for an unspecified indication, start and stop date were not reported; levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient previously took BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on 22Feb2021 (age at vaccination 63-year-old) as a single dose for COVID-19 immunization and experienced itchy rash all over body, thought it was hives. On an unspecified date in 2021, the patient experienced second shot was received- rash became worse. Clinical course: 3 days after first vaccine, itchy rash all Over body - thought it was hives, rash continued and second shot was received- rash became worse, now 2 weeks after second rash and 6 days course of steroids, Rash is still present and worse as steroids tapered. Therapeutic measures were taken as a result of second shot was received- rash became worse included Zyrtec and Steroids. The event resulted in doctor or other health care professional office/clinic visit. The outcome of the event was not recovered.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient received 2nd set of shots (Dtap-IPV-Hib-PCV13-MMR-Var) on 10/3/16. Mother called on 10/6/16 & stated that patient ran a fever on 10/4 and 10/5 but on 10/6, woke up and "face was swollen and small red bumps all over his body". Advised to go see PMD. On 10/11/16, I called to check on patient and Mother informed that he remained the same today.  Stated she did could not get in to see the Doctor on 10/6.  Advised her today that she should take him in to see Doctor. Verbalized understanding.
large red spot around injection site approx 3 to 4 inches in diameter, hot to the touch, itchy, hard lump at injection site on day 9 and 10 from 1st injection
The day after my arm was sore and red which i thought was normal after a vaccine, however, today is day 5 and it is more red and itchy. It looks like a hives on my right arm where the injection was placed. I have never had a reaction to a vaccine before.
approximately 36 hours after receiving vaccine, patient had fever, chills, and tachycardia off and on for 1 day. Patient has recovered.
Fatigue for the day he received the first dose.; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient of unspecified age who received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fatigue for the day he received the first dose. Outcome for the event was resolved on unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
low grade fever; bad chills; Hallucinations through fever and chills all night; bad stomach pain; headache; horrible diahrrea; Dose Number: 1, Date of start of drug: 9-MAR-2021/Dose Number: 2, Date of start of drug: 23-MAR-2021; Dose Number: 1, Date of start of drug: 9-MAR-2021/Dose Number: 2, Date of start of drug: 23-MAR-2021; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female non pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 23Mar2021 09:00 (Batch/Lot Number: Unknown) as single dose for covid-19 immunization.  Medical history included none. No allergies to medications, food, or other product. Concomitant medication included paracetamol (TYLENOL 8 HOUR) taken for an unspecified indication, start and stop date were not reported. No other vaccines received within 4 weeks prior to the COVID vaccine. The patient previously received dose 1 via an unspecified route of administration, administered in Arm Right on 09Mar2021 09:30 (Batch/Lot Number: unknown) as SINGLE DOSE for covid-19 immunization. The patient experienced bad stomach pain and 12 hours later low-grade fever bad chills on 24Mar2021 04:00, hallucinations through fever and chills all night, headache and horrible diarrhea. Adverse events start time was reported as 16:00 on 23Mar2021. It was unknown if the patient received treatment for the events stomach pain, fever, chills, Hallucinations, headache and diarrhea. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events stomach pain, fever, chills, Hallucinations, headache and diarrhea were recovering, of other event as unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Urticaria (hives) that would appear on different parts of the body every day or two for 4 months. It began with large welts on the hands and feet, then moved on to various parts of the body.  Each time, hives would appear on one area of the body, then go away within 20-30 minutes with the antihistamine Allegra.  Each month, the size of the hives would get smaller. During the fifth month (November 2021)  hives appeared twice and the size of the hives are very small.
6 days ago he got his first COVID-19 vaccination.  5 days ago he started to feel ill.  Generalized body aches.  Progressive shortness of breath.  More recently dry cough.  Diminished sense of taste and smell.  His symptoms progressed and today, due to shortness of breath, he presented to the ED.  In the ED he was found to be hypoxic and have tachypnea.  COVID-19 test was positive.  He was given intravenous dexamethasone and is referred to the hospitalist service for admission.  Patient denies ill contacts.  He denies diarrhea.  No nausea or vomiting.  Since arriving to the ED and getting on oxygen he feels significantly better.